1994
DOI: 10.1016/0006-8993(94)90266-6
|View full text |Cite
|
Sign up to set email alerts
|

Differential control of glucoregulatory hormone response and glucose metabolism by NMDA and kainate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

1998
1998
2008
2008

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(8 citation statements)
references
References 32 publications
0
8
0
Order By: Relevance
“…In our study, the stimulatory effect was observed 5 min after injection, and the normal TSH levels did not recover at 60 min. Yousef et al [16]confirmed the stimulatory effect of NMDA or KA on corticosterone release. In our experiment conditions, the stimulatory effect of glutamatergic agonist on the release of hormones by peripheral gland (thyroid) was less than that observed with corticosterone, though the increase in serum T4 and T3 levels was induced at 30 min with both types of glutamate agonists.…”
Section: Discussionmentioning
confidence: 57%
“…In our study, the stimulatory effect was observed 5 min after injection, and the normal TSH levels did not recover at 60 min. Yousef et al [16]confirmed the stimulatory effect of NMDA or KA on corticosterone release. In our experiment conditions, the stimulatory effect of glutamatergic agonist on the release of hormones by peripheral gland (thyroid) was less than that observed with corticosterone, though the increase in serum T4 and T3 levels was induced at 30 min with both types of glutamate agonists.…”
Section: Discussionmentioning
confidence: 57%
“…The lower IL-1␤ mRNA expression at 5 hr compared to 2 and 12 hr may reflect an inhibition of expression by sIL-1ra or icIL-1ra (Watson et al, 1995;Dinarello, 1996), or by circulating factors such as corticosteroids (Kern et al, 1988;Yousef et al, 1994;Dinarello, 1996;Kent et al, 1996). I.p.…”
Section: Discussionmentioning
confidence: 96%
“…I.p. administration of NMDA or kainic acid results in elevated levels of circulating ACTH and corticosterone (Yousef et al, 1994;Kent et al, 1996), which may cause an inhibition of IL-1␤ synthesis in a negative feedback fashion (Besedovsky et al, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…7 In the present study, the levels of circulating insulin, glucagon, and corticosterone were manipulated by the administration of specific agonists, blockers, and antagonists in order to suppress the induction of hepatic and renal Glu-6-Pase and Phentolamine and propranolol as adrenergic blockers, cyclic somatostatin as a glucagon blocker, and exogenous insulin were used prior to hemorrhage or along with fluid resuscitation to accomplish this objective. It has been reported that adrenergic and glucagon blockers are effective in preventing the glucose production in endotoxic 8,9 and septic 10 rats, and insulin is known to suppress the Glu-6-Pase gene expression. 3 In this regard, our hypothesis is that fluid optimization, per se, following hemorrhage will not prevent the induction of Glu-6-Pase gene expression and hyperglycemia and, thus, pharmacologic agents will still be needed to correct the problem.…”
mentioning
confidence: 99%